secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2024-07-05T23:59:59+00:00
Accession:  0001493152-24-026335
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncocyte annual meeting elects directors, ratifies auditor; Board confirms Arno independence
--------------------------------------------------------------------------------

- Shareholders elected four director nominees (Riggs, Arno, Last, Silverman) with ~7.98M votes each; quorum 81.5%.
- Ratified Marcum LLP as auditor for FY2024: 10.8M for, 10.9k against, 11k abstain.
- Approved non-binding say-on-pay proposal: 8.12M for, 20k against, 11k abstain.
- Board determined Andrew Arno independent per Nasdaq rules as of July 1, 2024; Arno chairs Compensation, Last chairs Audit, Silverman chairs Nominating.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315224026335/0001493152-24-026335-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315224026335/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-026335

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer